Profit

Buy Glenmark, hold Cipla shares: Nirmal Bang

PUBLISHED ON: August 2, 2012 | Duration: 4 min, 58 sec

facebooktwitteremailkoo
loading..
Praful Bohra, Sr. Research Analyst - Pharmaceuticals at Nirmal Bang Institutional Equities speaks about the pharma sector. He advises investors to hold Cipla shares with a target of Rs 379 and buy Glenmark shares with a target price of Rs 462.
ALSO WATCH
"If Government Action Was Enough, Why Is WHO Still Flagging Indian-Made Drugs?" Asks Expert

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com